{
  "report_rows": [
    {
      "kpi": "Diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$11.25 vs. cons $10.41",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.15B vs. cons $2.97B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Ending backlog",
      "prediction": "BEAT",
      "answer": "pred ~$13.05B vs. cons $12.70B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Same-store revenue growth",
      "prediction": "BETTER",
      "answer": "guide ~30.0% vs. cons 28.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core gross-margin commentary",
      "prediction": "BETTER",
      "answer": "guide ~25.0% vs. cons 24.5% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Capital expenditures as a share of revenue",
      "prediction": "UNCHANGED",
      "answer": "guide ~5.0% vs. cons 5.0% (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 5.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 8.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FY2026 EPS revisions should move to ~$46.00 versus consensus $43.63 as the EPS/revenue beat, backlog expansion, and higher same-store-growth outlook extend the out-period earnings-power debate rather than merely benefiting the reported quarter.",
  "day5_confidence": "MEDIUM"
}